GLP-1 medications, which include drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, are increasingly being recognized for their potential to treat not only type 2 diabetes but also obesity. Recent studies have shown that these medications may reduce the risk of heart attacks, dementia, and other health complications, making them an attractive option for patients dealing with multiple comorbidities. However, doctors caution that only a small percentage of eligible adults are prescribed these drugs, despite their potential benefits.
Dr. John Anderson, a diabetes specialist, highlights that the most critical candidates for GLP-1 medications are those with obesity accompanied by additional health conditions such, as type 2 diabetes, hypertension, sleep apnea, and significant osteoarthritis. While anyone who is obese and wants to lose weight could be considered a candidate, doctors stress that the highest-risk patient population should be prioritized. Dr. Anderson also notes that early treatment of obesity with GLP-1 medications can significantly reduce the progression of diseases like diabetes and improve overall health outcomes.
Dr. Michael Aziz, a regenerative medicine specialist, emphasizes the importance of lifestyle changes before considering weight-loss drugs, noting that these medications should be used in conjunction with healthy eating, exercise, and stress management. He also explains that insurance coverage for weight-loss medications is typically available for patients with a BMI over 27, though some patients may benefit from these drugs even with a lower BMI. Additionally, there is growing interest in the potential of GLP-1 medications to help treat conditions like alcoholism, Alzheimer’s, and liver disease, though more research is needed to confirm these effects.
Despite their benefits, GLP-1 medications can have side effects, including gastrointestinal issues, and certain individuals, such as those with a family history of medullary thyroid cancer or pancreatitis, may need to avoid them. Doctors also warn that these medications should not be taken indefinitely and should be combined with lifestyle changes for the best results. Patients are encouraged to consult with their physicians to fully understand the potential benefits and risks of these weight-loss drugs.